Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Business Insurance
In the News
Migraine meds on rise in comp despite overall drop in scripts
Business Hangout
In the News
Drug Use Insights: Migraines Rise While Opioids Decline
Claims Journal
In the News
Enlyte: Migraine Medications Continue Rising in Workers’ Comp
Workers' Comp
News Release
Enlyte Drug Trend Report: Migraine Med Use Soars in Comp Despite Overall Drop in Scripts
Annual PBM report shows increases in overall migraine meds use by nearly 9%, while opioids drop by almost 8%SAN DIEGO – April 30,
WorkCompWire
Article
Bill Review is Complex… Here’s How to Make it Easier and More Efficient
Bill review is complex — but the right approach can unlock major savings. Learn how to streamline the process and boost efficiency.
Mitchell
News Release
Mitchell Launches Cloud-Native Guidewire Integration to Help Insurers Expedite Claims Processing
SAN DIEGO, Calif.—Mitchell, a leader in the development of innovative auto physical damage technology solutions, today announced t